Estrogen is NOT used commonly for the treatment of osteoporosis because:

The selective estrogen receptor modulator (SERM) raloxifene (Evista®) acts as an estrogen agonist at various sites throughout the body, such as bone, but as an estrogen antagonist at other sites. This agonist/antagonist combination results in a variety of adverse events including:

A patient with severe respiratory muscle weakness develops a PaCO₂ of 58 mmHg and a decreased PaO₂. Lung imaging shows no significant parenchymal disease. Which mechanism best explains these abnormalities?

Which explanation best links the enzyme defect in PKU to the patient’s clinical findings?

A patient has recurrent invasive infections with Neisseria species. Which immune defect is most likely?

A patient with vitamin B12 deficiency develops paresthesias and loss of vibration sensation in both feet. Which mechanism explains these neurologic findings?

Two patients have an SpO₂ of 88%. Patient A has pneumonia with low V/Q regions. Patient B has extensive alveolar collapse with significant intrapulmonary shunt. Why might supplemental oxygen produce a greater improvement in Patient A?

Inflammation contributes to microvascular thrombosis during sepsis primarily through increased expression of:

Which statement best describes the plasma membrane?

A hospitalized patient has fever, tachycardia, and hypotension secondary to bacterial sepsis. Which change most directly contributes to the development of hypotension?